ArticleCancer management and research2019

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.

Pamela Munster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.